Renal cell carcinoma, part 1.
Journal
Nursing
ISSN: 1538-8689
Titre abrégé: Nursing
Pays: United States
ID NLM: 7600137
Informations de publication
Date de publication:
01 Jul 2021
01 Jul 2021
Historique:
entrez:
22
6
2021
pubmed:
23
6
2021
medline:
29
6
2021
Statut:
ppublish
Résumé
Renal cell carcinoma (RCC) encompasses a group of malignancies that originate in the epithelium of the renal cortex, most often in the upper pole of the kidney. This article, the first of a three-part series on RCC, addresses the incidence and epidemiology of RCC along with its genetic alterations, risk factors, histologic characteristics, and imaging characteristics.
Identifiants
pubmed: 34156999
doi: 10.1097/01.NURSE.0000753972.19135.dc
pii: 00152193-202107000-00009
doi:
Types de publication
Journal Article
Langues
eng
Pagination
34-40Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Siddiqui SN, Haas CR, McKiernan JM. Epidemiology, screening, and clinical staging. In: Libertino JA, Gee JR, eds. Renal Cancer: Contemporary Management . 2nd ed. Cham, Switzerland: Springer; 2020.
Harris RE. Epidemiology of kidney cancer. In: Harris Epidemiology of Chronic Disease: Global Perspectives . 2nd ed. Burlington, MA: Jones and Bartlett Learning; 2020.
American Cancer Society. Key statistics about kidney cancer. 2021. www.cancer.org/cancer/kidney-cancer/about.html .
Mikami S, Kuroda N, Nagashima Y. Pathology of renal cell carcinoma. In: Oya M, ed. Renal Cell Carcinoma: Molecular Features and Treatment Updates . Tokyo, Japan: Springer; 2017.
Batai K, Harb-De la Rosa A, Lwin A, et al. Racial and ethnic disparities in renal cell carcinoma: an analysis of clinical characteristics. Clin Genitourin Cancer . 2019;17(1):e195–e202.
Francis F, Zhou M. Pathology of renal cell carcinoma. In: Libertino JA, Gee JR, eds. Renal Cancer: Contemporary Management . 2nd ed. Cham, Switzerland: Springer; 2020.
Wu X, Shu X. Epidemiology of renal cell carcinoma. In: Oya M, ed. Renal Cell Carcinoma: Molecular Features and Treatment Updates . Tokyo, Japan: Springer; 2017.
Al-Bayati O, Hasan A, Pruthi D, Kaushik D, Liss MA. Systematic review of modifiable risk factors for kidney cancer. Urol Oncol . 2019;37(6):359–371.
Zhang S, Jia Z, Yan Z, Yang J. Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies. Oncotarget . 2017;8(17):27892–27903.
The Johns Hopkins Lupus Center. Lupus and cancer. www.hopkinslupus.org/lupus-info/lifestyle-additional-information/lupus-cancer .
Song L, Wang Y, Zhang J, Song N, Xu X, Lu Y. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis. Arthritis Res Ther . 2018;20(1):270.
Ball MW, Pinto PA. Familial and hereditary syndromes in renal cell carcinoma. In: Libertino JA, Gee JR, eds. Renal Cancer: Contemporary Management . 2nd ed. Cham, Switzerland: Springer; 2020.
Quddus MB, Pratt N, Nabi G. Chromosomal aberrations in renal cell carcinoma: an overview with implications for clinical practice. Urol Ann . 2019;11(1):6–14.
Maher ER. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management. World J Urol . 2018;36(12):1891–1898.
Plon SE, Jonasch E. Clinical features, diagnostics, and management of von Hippel-Lindau disease. UpToDate. 2020. www.uptodate.com .
Warren AY, Harrison D. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies. World J Urol . 2018;36(12):1913–1926.
Williamson SR, Gill AJ, Argani P, et al. Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: III: molecular pathology of kidney cancer. Am J Surg Pathol . 2020;44(7):e47–e65.
Sirohi D, Smith SC, Agarwal N, Maughan BL. Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities. Res Rep Urol . 2018;10:205–217.
Afnan J, Therrien JA, Wald C. Imaging of renal cancer. In: Libertino JA, Gee JR, eds. Renal Cancer: Contemporary Management . 2nd ed. Cham, Switzerland: Springer; 2020.
van Oostenbrugge TJ, Fütterer JJ, Mulders PFA. Diagnostic imaging for solid renal tumors: a pictorial review. Kidney Cancer . 2018;2(2):79–93.
Patel HD, Nichols PE, Su ZT, et al. Renal mass biopsy is associated with reduction in surgery for early-stage kidney cancer. Urology . 2020;135:76–81.
de Leon AD, Pedrosa I. Imaging and screening of kidney cancer. Radiol Clin North Am . 2017;55(6):1235–1250.
Reinhard R, van der Zon-Conijn M, Smithuis R. Kidney—solid masses. Radiology Assistant. https://radiologyassistant.nl/abdomen/kidney-solid-masses .
MRI interpretation. T1 v T2 images. Radiology Master Class. 2017. www.radiologymasterclass.co.uk/tutorials/mri/t1_and_t2_images .
Vos N, Oyen R. Renal angiomyolipoma: the good, the bad, and the ugly. J Belg Soc Radiol . 2018;102(1):41.
American Urological Association. Renal mass and localized renal cancer: AUA guideline. 2017. www.auanet.org/guidelines/renal-cancer-renal-mass-and-localized-renal-cancer-guideline .